Market revenue in 2023 | USD 86.2 million |
Market revenue in 2030 | USD 225.3 million |
Growth rate | 14.7% (CAGR from 2023 to 2030) |
Largest segment | Biorepository services |
Fastest growing segment | Biorepository Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biorepository Services, Archiving Solution Services |
Key market players worldwide | Azenta Inc, Thermo Fisher Scientific Inc, Precision for Medicine, Medpace Holdings Inc, Labcorp Drug Development, ATCC, Q2 Solutions, LabConnect, Charles River Laboratories International Inc |
Biorepository services was the largest segment with a revenue share of 66.36% in 2023. Horizon Databook has segmented the South Korea clinical trial biorepository & archiving solutions market based on biorepository services, archiving solution services covering the revenue growth of each sub-segment from 2018 to 2030.
Clinical trial biorepository & archiving solutions market in South Korea is expected to exhibit gradual growth during the forecast period. South Korea has become one of the top Asian countries for conducting clinical trials owing to the presence of quality clinical research infrastructure. Moreover, the country has recently implemented various protection and safety requirements for clinical trial participants.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account